VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 681 filers reported holding VANECK VECTORS ETF TR in Q3 2021. The put-call ratio across all filers is 1.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $611,237 | +44.9% | 18,012 | +19.3% | 0.08% | +203.8% |
Q1 2024 | $421,894 | -9.9% | 15,100 | 0.0% | 0.03% | -10.3% |
Q4 2023 | $468,251 | -32.2% | 15,100 | -10.8% | 0.03% | -37.0% |
Q3 2023 | $690,317 | -40.6% | 16,928 | -56.2% | 0.05% | -38.7% |
Q2 2023 | $1,162,508 | -53.5% | 38,609 | -50.0% | 0.08% | -11.8% |
Q1 2023 | $2,497,982 | +126.2% | 77,218 | +100.0% | 0.08% | +9.0% |
Q4 2022 | $1,104,525 | +19.0% | 38,609 | +0.4% | 0.08% | +2.6% |
Q3 2022 | $928,000 | -8.2% | 38,461 | 0.0% | 0.08% | 0.0% |
Q2 2022 | $1,011,000 | -31.2% | 38,461 | +0.4% | 0.08% | -25.5% |
Q1 2022 | $1,469,000 | +20.0% | 38,311 | +0.3% | 0.10% | +17.2% |
Q4 2021 | $1,224,000 | +40.4% | 38,211 | +29.2% | 0.09% | +33.8% |
Q3 2021 | $872,000 | -17.4% | 29,583 | -4.8% | 0.06% | -20.7% |
Q2 2021 | $1,056,000 | +41.6% | 31,088 | +35.5% | 0.08% | +28.1% |
Q1 2021 | $746,000 | +32.3% | 22,943 | +46.6% | 0.06% | +20.8% |
Q4 2020 | $564,000 | 0.0% | 15,650 | +8.7% | 0.05% | -8.6% |
Q3 2020 | $564,000 | +9.1% | 14,400 | +2.1% | 0.06% | +7.4% |
Q2 2020 | $517,000 | +59.6% | 14,100 | 0.0% | 0.05% | +42.1% |
Q1 2020 | $324,000 | -21.5% | 14,100 | 0.0% | 0.04% | -5.0% |
Q4 2019 | $413,000 | +9.5% | 14,100 | 0.0% | 0.04% | +5.3% |
Q3 2019 | $377,000 | +6.5% | 14,100 | +1.8% | 0.04% | +2.7% |
Q2 2019 | $354,000 | +20.8% | 13,850 | +6.1% | 0.04% | +19.4% |
Q1 2019 | $293,000 | +6.5% | 13,050 | 0.0% | 0.03% | -3.1% |
Q4 2018 | $275,000 | +13.6% | 13,050 | 0.0% | 0.03% | +18.5% |
Q3 2018 | $242,000 | -10.4% | 13,050 | +8.0% | 0.03% | -10.0% |
Q2 2018 | $270,000 | +6.3% | 12,080 | +4.3% | 0.03% | +7.1% |
Q1 2018 | $254,000 | -3.8% | 11,578 | +1.7% | 0.03% | -3.4% |
Q4 2017 | $264,000 | +6.5% | 11,380 | +5.6% | 0.03% | 0.0% |
Q3 2017 | $248,000 | +4.2% | 10,780 | 0.0% | 0.03% | +3.6% |
Q2 2017 | $238,000 | -2.1% | 10,780 | 0.0% | 0.03% | -6.7% |
Q1 2017 | $243,000 | +7.5% | 10,780 | 0.0% | 0.03% | +3.4% |
Q4 2016 | $226,000 | -20.7% | 10,780 | 0.0% | 0.03% | -21.6% |
Q3 2016 | $285,000 | -4.7% | 10,780 | 0.0% | 0.04% | -14.0% |
Q2 2016 | $299,000 | – | 10,780 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $21,165,410 | 69.82% |
New Harbor Financial Group, LLC | 1,523,632 | $43,667,279 | 18.06% |
Cadence Wealth Management LLC | 617,285 | $17,691,382 | 15.17% |
Windmill Hill Asset Management Ltd | 798,150 | $22,874,979 | 14.71% |
Slate Path Capital LP | 8,755,000 | $250,918,300 | 13.50% |
SPX Gestao de Recursos Ltda | 3,997,000 | $114,554,020 | 12.37% |
New Harbor Financial Group, LLC | 704,500 | $20,190,970 | 8.35% |
Eschler Asset Management LLP | 150,000 | $4,299,000 | 8.15% |
Hollow Brook Wealth Management LLC | 527,007 | $15,104,021 | 7.23% |
Yong Rong (HK) Asset Management Ltd | 400,000 | $11,464 | 7.22% |